Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1851
iShares 7-10 Year Treasury Bond ETF
IEF
$47.2B
| $3.48M | ﹤0.01% |
28,600
+23,800
| +496% | +$2.89M |
|
|
TGB
1852
Trekor Metals
TGB
$3.06B
| $3.47M | ﹤0.01% |
7,015,437
-1,413,216
| -17% | -$539K |
|
|
NWLI
1853
DELISTED
National Western Life Group, Inc. Class A
NWLI
| $3.46M | ﹤0.01% |
17,002
-5,100
| -23% | -$972K |
|
1854
Karyopharm Therapeutics
KPTI
$45.8M
| $3.44M | ﹤0.01% |
12,120
-23,480
| -66% | -$6.94M |
|
|
OIIM
1855
DELISTED
02Micro International
OIIM
| $3.44M | ﹤0.01% |
2,024,081
+11,907
| +0.6% | +$17.3K |
|
|
TRIB
1856
Trinity Biotech
TRIB
$7.88M
| $3.44M | ﹤0.01% |
10,521
+4,693
| +81% | +$1.07M |
|
1857
Equity Bancshares
EQBK
$1.06B
| $3.43M | ﹤0.01% |
196,900
-9,100
| -4% | -$151K |
|
1858
Silvercrest Asset Management
SAMG
$79.6M
| $3.43M | ﹤0.01% |
270,210
-29,414
| -10% | -$312K |
|
|
JNCE
1859
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $3.43M | ﹤0.01% |
496,614
-203,500
| -29% | -$1.1M |
|
1860
Entravision Communication
EVC
$832M
| $3.42M | ﹤0.01% |
2,392,643
+197,600
| +9% | +$307K |
|
1861
Globant
GLOB
$1.61B
| $3.42M | ﹤0.01% |
+22,800
| New | +$2.82M |
|
|
MASI
1862
DELISTED
Masimo
MASI
| $3.4M | ﹤0.01% |
14,900
-4,100
| -22% | -$900K |
|
1863
iShares California Muni Bond ETF
CMF
$4.62B
| $3.39M | ﹤0.01% |
54,500
+39,100
| +254% | +$2.4M |
|
1864
Vera Bradley
VRA
$93M
| $3.38M | ﹤0.01% |
760,700
-262,859
| -26% | -$1.31M |
|
1865
Eastman Chemical
EMN
$8.47B
| $3.37M | ﹤0.01% |
+48,440
| New | +$3.05M |
|
|
ORBC
1866
DELISTED
ORBCOMM, Inc.
ORBC
| $3.37M | ﹤0.01% |
875,205
-522,933
| -37% | -$1.56M |
|
|
NOA
1867
North American Construction
NOA
$375M
| $3.37M | ﹤0.01% |
538,200
-214,100
| -28% | -$1.21M |
|
1868
RF Industries
RFIL
$148M
| $3.37M | ﹤0.01% |
722,177
+12,937
| +2% | +$65.8K |
|
1869
Richardson Electronics
RELL
$299M
| $3.36M | ﹤0.01% |
830,373
+10,490
| +1% | +$42K |
|
1870
Global Water Resources
GWRS
$247M
| $3.36M | ﹤0.01% |
318,447
+13,300
| +4% | +$140K |
|
1871
DigitalBridge
DBRG
$2.94B
| $3.35M | ﹤0.01% |
349,049
-1,365,832
| -80% | -$11.9M |
|
1872
SI-BONE Inc
SIBN
$848M
| $3.34M | ﹤0.01% |
209,700
-14,800
| -7% | -$233K |
|
|
NGM
1873
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $3.34M | ﹤0.01% |
169,000
+19,900
| +13% | +$380K |
|
1874
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
$17.3B
| $3.33M | ﹤0.01% |
+55,200
| New | +$3.23M |
|
|
MN
1875
DELISTED
MANNING & NAPIER, INC.
MN
| $3.32M | ﹤0.01% |
1,162,068
-2,681
| -0.2% | -$7.6K |
|
Similar funds
Jim Simons's Q2 2020 Portfolio in Review
As of Q2 2020, Jim Simons held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,366 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Jim Simons opened a new position in Uber worth $187M.
- Jim Simons's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Jim Simons added most to Zoom in Q2 2020, an estimated $806M increase.
- Jim Simons's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Jim Simons fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Jim Simons's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Jim Simons opened 584 new positions and closed 596 in Q2 2020.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.